Polar Asset Management Partners’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-166,145
Closed -$10.5M 1340
2021
Q3
$10.5M Buy
166,145
+78,645
+90% +$5.99M 0.1% 230
2021
Q2
$8.01M Buy
+87,500
New +$6.96M 0.08% 269
2019
Q1
Sell
-398,337
Closed -$10M 361
2018
Q4
$10M Buy
+398,337
New +$10.2M 0.2% 112
2018
Q3
Sell
-217,557
Closed -$2.66M 366
2018
Q2
$2.66M Sell
217,557
-643,143
-75% -$7.38M 0.05% 249
2018
Q1
$6.86M Buy
+860,700
New +$5.31M 0.11% 160

Other funds holding CDNA

Polar Asset Management Partners's CDNA Position: Q4 2021 in Review

Polar Asset Management Partners sold out of CareDx (CDNA) in Q4 2021, closing a stake of 166,145 shares — an estimated $10.5M sold.

Polar Asset Management Partners first reported a position in CDNA in Q1 2018 and held it in 5 quarters. The position peaked at $10.5M in Q3 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.

  • Polar Asset Management Partners reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
  • Polar Asset Management Partners sold 166,145 CareDx shares in Q4 2021, an estimated $10.5M.
  • Polar Asset Management Partners first reported a position in CareDx in Q1 2018 and held it in 5 quarters.
  • Polar Asset Management Partners's CareDx position peaked at $10.5M in Q3 2021.
  • 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.

Based on Polar Asset Management Partners's 13F filing for Q4 2021, filed 14 Feb 2022.